Lonza TheraPEAK FGM-CD fibroblast growth medium

Friday, 22 July, 2011 | Supplied by: Capsugel Australia Pty Ltd

Lonza TheraPEAK FGM-CD fibroblast growth medium

TheraPEAK FGM-CD fibroblast growth medium - chemically defined and without phenol red and antibiotics - is designed to support the growth and proliferation of primary human dermal fibroblasts in culture.

The medium supports growth and proliferation of both adult and neonatal primary human dermal fibroblasts. Features include: maintains normal fibroblast characteristics comparable to serum-containing media; and supports growth of fibroblasts on tissue culture vessels from a variety of manufacturers with no requirement for pre-treatment with an attachment matrix.

The media is supplied in BulletKit format with basal medium and supplement for growth and proliferation. The media is suitable for further manufacturing or lab research use.

Online: lonzabioscience.com.au
Phone: 1300 657508
Related Products

Biosensis MAP2 antibodies

Biosensis's validated MAP2 antibodies are designed to help users identify MAP2, whether they...

Bio-Rad Laboratories Celselect Slides validated antibodies for rare cell and CTC enumeration

The antibodies are specific to CTC surface markers to enable the sensitive and specific...

Microbiologics UV-BioTAG QC microorganisms for quality control testing

UV-BioTAG, a line of reference strains containing green fluorescent protein (GFP) markers, makes...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd